FDA Adverse Event Malfunction Summary report: N

REVANESSE VERSA

MDR report key: 9378899 · Received November 26, 2019

Report

Report Number
3004423487-2019-00006
Event Type
Malfunction
Date Received
November 26, 2019
Report Date
September 12, 2018
Manufacturer
PROLLENIUM MEDICAL TECHNOLOGIES INC
Product Code
LMH
PMA / PMN Number
P160042
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

1 .CORRECTION TO SECTION E1 FROM INITIAL REPORT:- CHANGED THE MDR REPORTER COUNTRY FROM CANADA TO USA.

Additional Manufacturer Narrative · 1

DEVICE HISTORY RECORD SUMMARY: THE RETROSPECTIVE REVIEW OF THE BATCH RECORD SHOWS THAT NO ELEMENT CAUSING THE ISSUE. ALL QUALITY CONTROL HAVE PASSED AND THERE WAS NO LIDOCAINE CONTAIN ADDED. EACH OF THE SYRINGE WERE VISUALLY INSPECTED AFTER FILLING AND NO CONTAMINATION WERE DETECTED.

Description of Event or Problem · 1

THE PATIENT GOT HER INJECTION (REVANESSE VERSA - LOT 18G065) ON (B)(6) 2018. INITIALLY THERE WERE BRUISING AND SOME LUMP UNDER HER EYES. AFTER TWO AND A HALF WEEKS LATER THE LUMP WENT DOWN BUT STILL RETAINED SOME PUFFINESS. THE PATIENT WAS CONCERNED ABOUT THOSE IRREGULAR LUMP / PUFFINESS UNDER HER EYES, BECAUSE SHE WAS ABLE TO SEE THE PUFFINESS UNDER HER EYES WITH HER PERIPHERAL VISION WHEN SHE WAS SITTING DOWN. THE PATIENT THINKS THE SITUATION WAS GETTING WORSE, THAT HER VISION WAS BEING AFFECTED TOO.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1174841 REVANESSE VERSA REVANESSE VERSA LMH PROLLENIUM MEDICAL TECHNOLOGIES INC 40081 18G065

Patients

Seq Age Sex Outcome Treatment
1